NCT04089943View on ClinicalTrials.gov

The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD

NAActive, not recruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

August 29, 2024

Study Completion Date

August 25, 2025

Conditions
Peripheral Arterial DiseaseVascular Diseases, PeripheralArterial Occlusive DiseasesAtherosclerosis
Interventions
PROCEDURE

Revascularization operation

Participants will be randomized into an endovascular or open bypass procedure.

OTHER

Control group

Healthy non-PAD participants will be recruited for the study.

Trial Locations (2)

76508

Baylor Scott and White, Temple

78712

UT Austing Dell Medical School, Austin

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of West Florida

OTHER